๐Ÿ•ต๏ธ Protagenic Therapeutics, INC.\NEW ($PTIX)

SEC insider & ownership activity, last 12 months ยท CIK 1022899 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. 3 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Dec 31, 2025.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)Mar 31, 2026 filing โ†—
Material agreement (1.01)Feb 17, 2026 filing โ†—
Agreement terminated (1.02)Feb 17, 2026 filing โ†—
Acquisition or disposition (2.01)Feb 17, 2026 filing โ†—
Unregistered equity sale (3.02)Feb 17, 2026 filing โ†—
Other events (8.01)Feb 17, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Feb 17, 2026 filing โ†—
Officer/director changes (5.02)Feb 3, 2026 filing โ†—
Delisting notice (3.01)Dec 31, 2025 filing โ†—
Delisting notice (3.01)Nov 20, 2025 filing โ†—
Reg FD disclosure (7.01)Nov 20, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Nov 20, 2025 filing โ†—
Officer/director changes (5.02)Nov 3, 2025 filing โ†—
Other events (8.01)Oct 28, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Oct 28, 2025 filing โ†—
Delisting notice (3.01)Aug 7, 2025 filing โ†—
Auditor change (4.01)Aug 7, 2025 filing โ†—
Reg FD disclosure (7.01)Aug 7, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Aug 7, 2025 filing โ†—
Exit or disposal costs (2.05)Aug 7, 2025 filing โ†—
Officer/director changes (5.02)Aug 7, 2025 filing โ†—
Charter/bylaw changes (5.03)Aug 7, 2025 filing โ†—
Other events (8.01)Aug 7, 2025 filing โ†—
Reg FD disclosure (7.01)Jul 18, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Jul 18, 2025 filing โ†—
Financial Statements and Exhibits (9.01)May 15, 2025 filing โ†—
Financial Statements and Exhibits (9.01)May 15, 2025 filing โ†—